YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Supporting the $1000 Genome


February 10, 2012 | With the $1,000 genomic sequencing barrier looming, the question remains whether we'll be able to make sense of the data to come pouring off sequencers like Life Technologies' new Ion Proton Sequencer. Colin Hill, CEO of GNS Healthcare argues that the infrastructure is ready in this commentary. Forbes
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.